Trial Profile

Phase IIb/III trial of ISR-48 in newly diagnosed HIV-infected patients

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 27 Mar 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Triptorelin (Primary)
Indications HIV-1 infections
Focus Registrational; Therapeutic Use
Sponsors Immune System Regulation

Most Recent Events

27 Mar 2018 New trial record
01 Dec 2017 Accoding to Immune System Regulation media release, discussions are still under way to find solutions to the ethical aspects of this study and alternative countries for the study, including China and Far East Asia.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com